Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance
Anastasia‐Maria Zavitsanou, Ray Pillai, Hao Yuan, et al.
Cell Reports (2023) Vol. 42, Iss. 11, pp. 113295-113295
Open Access | Times Cited: 46

Showing 26-50 of 46 citing articles:

KEAP1-Mutant Lung Cancers Weaken Anti-Tumor Immunity and Promote an M2-like Macrophage Phenotype
Christopher J. Occhiuto, Karen T. Liby
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3510-3510
Open Access | Times Cited: 1
Redox high phenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mutations diminishes tissue-resident memory CD8+ T cells and attenuates the efficacy of immunotherapy in lung adenocarcinoma
Xue‐Wu Wei, Chang Lu, Yichen Zhang, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
A graphSAGE discovers synergistic combinations of Gefitinib, paclitaxel, and Icotinib for Lung adenocarcinoma management by targeting human genes and proteins: the RAIN protocol
Sogand Sadeghi, Ali A. Kiaei, Mahnaz Boush, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Combined treatment for a rare malignant glomus tumor of the esophagus with pulmonary and liver metastases: a case report and review of literature
Yanan Liu, Jingjing Mao, Dongfeng Shen, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Genomic and molecular alterations associated with primary resistance to immune checkpoint inhibitors
Jyoti Malhotra, Subhajyoti De, Kim B. Nguyen, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 11
Open Access | Times Cited: 1
Biomarker potential of nuclear Nrf2 activation in the ABC subtype of diffuse large B‑cell lymphoma
Chin‐Mu Hsu, Shih‐Yu Kao, Chia‐Hung Yen, et al.
Oncology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
Exploring mechanisms of skin aging: insights for clinical treatment
Meiqi Zhang, Yumeng Lin, Zhongyu Han, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
NLRP12/C1qA positive feedback in tumor-associated macrophages regulates immunosuppression through LILRB4/NF-κB pathway in lung adenocarcinoma
Jiaxin Yin, Yuxiao Song, Yang‐Xin Fu, et al.
Cancer Immunology Immunotherapy (2024) Vol. 74, Iss. 1
Open Access | Times Cited: 1
Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer
Mark Zucker, Maria Perry, Samuel I. Gould, et al.
Cell (2024)
Open Access | Times Cited: 1
NRF2-dependent regulation of the prostacyclin receptor PTGIR drives CD8 T cell exhaustion
Michael S. Dahabieh, Lisa M. DeCamp, Brandon M. Oswald, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Mechanisms of primary resistance to immune checkpoint inhibitors in NSCLC
Georgia Gomatou, Andriani Charpidou, Peifeng Li, et al.
Clinical & Translational Oncology (2024)
Closed Access
Identification of anoikis-related long non-coding RNA signature as a novel prognostic model in lung adenocarcinoma
Xisheng Fang, Mei Wei, Xia Liu, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 10, pp. 5458-5472
Open Access
Somatic mutational landscape reveals mutational signatures and significantly mutated genes of cancer immunotherapeutic outcome and sex disparities
Yuting Li, Qinghua Wang, Xiaopan Gao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
The Impact of Genetic Mutations on the Efficacy of Immunotherapies in Lung Cancer
Ki Lui, Kwok‐Kuen Cheung, Winnie Wing Man Ng, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11954-11954
Open Access
Identification of Molecular Subtypes and Prognostic Traits Based on Chromosomal Instability Phenotype-Related Genes in Lung Adenocarcinoma
Youngsic Jeon, Kyung‐Chul Choi, Young Nyun Park, et al.
Cancers (2024) Vol. 16, Iss. 22, pp. 3818-3818
Open Access
Next-generation immunotherapy: igniting new hope for lung cancer
Molly Li, Antony C. S. Chan, Kevin Mok, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access
The Complex Roles of Redox and Antioxidant Biology in Cancer
Makiko Hayashi, Keito Okazaki, Thales Papgiannakopoulos, et al.
Cold Spring Harbor Perspectives in Medicine (2024) Vol. 14, Iss. 11, pp. a041546-a041546
Closed Access
Unveiling ferroptosis: a new frontier in skin disease research
Ke Wang, Yumeng Lin, Dan Zhou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
The miR-23a/27a/24-2 cluster drives immune evasion and resistance to PD- 1/PD-L1 blockade in non-small cell lung cancer
Hao Luo, Qing Li, Xiang-Rong Gu, et al.
Research Square (Research Square) (2024)
Open Access
Mechanisms of immunotherapy resistance in small cell lung cancer
Yunan Nie, Kurt A. Schalper, Anne C. Chiang
Cancer Drug Resistance (2024)
Open Access
The miR-23a/27a/24 − 2 cluster drives immune evasion and resistance to PD-1/PD-L1 blockade in non-small cell lung cancer
Hao Luo, Bin Hu, Xiang-Rong Gu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access
A novel human model to deconvolve cell-intrinsic phenotypes of genetically dysregulated pathways in lung squamous cell carcinoma
Julia Ogden, Robert M. Sellers, Sudhakar Sahoo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Previous Page - Page 2

Scroll to top